Aprea Therapeutics Inc logo

APRE - Aprea Therapeutics Inc News Story

$4.35 -0.1  -2.0%

Last Trade - 5:15pm

Sector
Healthcare
Size
Small Cap
Market Cap £68.3m
Enterprise Value £3.67m
Revenue £n/a
Position in Universe 5217th / 6854

U.S. RESEARCH ROUNDUP- Aprea Therapeutics, Beyondspring, Cognizant Technology

Tue 29th December, 2020 7:12am
Dec 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Aprea Therapeutics, Beyondspring and Cognizant
Technology Solutions on Tuesday. 
    
  HIGHLIGHTS        
     * Aprea Therapeutics Inc  APRE.O : Baird cuts to neutral from outperform
     * Beyondspring Inc  BYSI.O : Evercore ISI initiates coverage with outperform rating and $30 PT
     * Cognizant Technology Solutions Corp  CTSH.O : Credit Suisse raises PT to $91 from $79
     * Seer, Inc.  SEER.O : JP Morgan initiates coverage with overweight rating; target $75
                
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order.       
     * Amphenol Corp  APH.N : JP Morgan sets neutral rating with target price $138
     * Aprea Therapeutics Inc  APRE.O : Baird cuts target price to $5 from $45
     * Aprea Therapeutics Inc  APRE.O : Baird cuts to neutral from outperform
     * Aprea Therapeutics Inc  APRE.O : JP Morgan cuts target price to $6 from $31
     * Aprea Therapeutics Inc  APRE.O : RBC cuts target price to $10 from $40
     * Aprea Therapeutics Inc  APRE.O : RBC cuts to sector perform from outperform
     * Arcturus Therapeutics Holdings Inc  ARCT.O : Baird cuts target price to $69 from $79
     * Arcturus Therapeutics Holdings Inc  ARCT.O : Baird cuts to neutral from outperform
     * Beyondspring Inc  BYSI.O : Evercore ISI initiates coverage with outperform rating and $30 PT
     * Cognizant Technology Solutions Corp  CTSH.O : Credit Suisse raises PT to $91 from $79
     * Kilroy Realty Corp  KRC.N : Evercore ISI cuts target price to $65 from $66
     * Myovant Sciences Ltd  MYOV.N : JP Morgan raises target price to $38 from $30
     * Seer, Inc.  SEER.O : JP Morgan initiates coverage with overweight rating; target $75
     * Sigilon Therapeutics, Inc.  SGTX.O : Jefferies initiates coverage with buy rating; PT $60
       

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.